ALR Technologies SG Ltd (ALRTF)

[Giantsgal22]

Received this last night. No IR any longer so that was B.S.


Following is an email which I replied to a shareholder. Thought it addresses some of your concerns in more complete details.

Best

Sidney


“The shares have been trading for nearly 20 years. I have come to the conclusion that OTC investors is a fickle bunch (see attached chart). We do not need them to realize the full value of the assets of the Company. What we need is to develop an indispensable product that will:

1. Improve health outcome for diabetes patients
2. Generate unique data that the pharmaceuticals must have to keep up with their competitors for the marketing purposes
3. Generate unique data that private and government health plans can keep track of adherence to best practice guidelines by healthcare providers and adherence to care plan by patients

That is what the ALRT Diabetes Management Platform will do. You will see the full picture when we disclose the patented complimentary feature to Insulin Dose Adjustment. We expect to share that with the public within 45 days.

Frankly, since February 2015, we have been hard at work to get FDA clearance for Insulin Dose Adjustment and at the same time came up with the patented complimentary feature. (http://alrt.com/news/2015/02/15/alr-technologies-seeks-fda-approval-for-insulin-dose-adjustment-feature-for-better-diabetes-management) Obviously we cannot announce a proprietary process until it is developed and patent submitted. No one asked a single question regarding the progress of Insulin Dose Adjustment since the announcement of February, 2015. We only make announcements of facts not plans.

To realize full value of the ALRT asset, I need to provide an indispensable service to companies and organizations with hundreds of billions of dollars – pharmaceutical companies, health insurance companies and government health plans. This is exactly what we have accomplished. The value of the asset is not dependent on the price of the shares. The value of the asset is dependent on the value of service provided to the customers. We have developed an indispensable App for diabetes care. We have plans in place to bring the service to the global market and also have plans to get the attention of the companies and organizations with hundreds of billions of dollars that need our services. We will announce the plans as they become reality.

Judging from interest of investors since February 2015, we have not counted on this group for support. We thought there is no investor interest in ALR Tech and accordingly it was not priority for us to continue with IR and stay current with filings. Frankly we did not expect and are thankful for the reaction of the market to the Insulin Dose Adjustment announcement. We have contacted the SEC to seek their guidance on how to be current again in our filings. We have not heard back from the person in charge of our file. We will keep investors informed after we have made contact with the SEC on what the next steps are.

Thank you again for your interest and support.

Best

Sidney”